Is this you? Create Your Porfile
Avatar

Klaus Dr. Wirth

Aventis Pharma

Hotspot
Bubble
Bubble
[Coming Soon]
 Word Cloud
Cloud
 Mosaic Glass
Mosaic
[Coming Soon]

Archive | 1994

Use of Bradykinin-antagonists for the manufacture of a medicament for the prophylaxis and treatment of arteriosclerosis

Wolfgang Dr. Linz; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Breipohl; Stephan Henke; Jochen Knolle

Archive | 1997

(Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Nolken

Archive | 1993

Peptides with N-terminal modifications having bradykinin antagonistic activity

Gerhard Breipohl; Stephan Henke; Jochen Knolle; Bernward Prof. Dr. Schölkens; Hans-Georg Alpermann; Hermann Dr. Gerhards; Klaus Dr. Wirth

Archive | 1997

Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Max Hropot; Martin Bickel

Archive | 1997

Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists

Adalbert Wagner; Holger Heitsch; Gerhard Dr. Nölkne; Klaus Dr. Wirth; Bernard

Archive | 1997

Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease

Holger Heitsch; Gabriele Wiemer; Klaus Dr. Wirth

Archive | 1994

Use of bradykinin antagonists for the treatment of viral diseases

Fred Lembeck; Klaus Dr. Wirth; Irvin Winkler; Gerhard Breipohl; Stephan Henke; Jochen Knolle

Archive | 1996

New 1-(4-amino-benzyl)-pyrrolidine propionic acid derivatives

Adalert Dr Wagner; Gerhard Breipohl; Holger Heitsch; Hermann Dr. Gerhards; Gerhard Dr Noelken; Klaus Dr. Wirth; Bernward Prof Dr Schoelkens

Archive | 2004

Use of specific 2-substituted benzamides for treating and preventing cardiac insufficiency, especially where caused by diastolic dysfunction, act by inhibition of the Kv1.5 potassium channel

Klaus Dr. Wirth

Archive | 2004

Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them

Uwe Heinelt; Jochen-Hans Dr. Lang; Armin Hofmeister; Klaus Dr. Wirth; Hans-Willi Jansen

Explore More
Researchain Logo
Decentralizing Knowledge